documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
69 rows where document_type = "Other" and posted_year = 1994 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_month, posted_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1986-V-0022-0007 | FDA | Ion laser technology series ILT 5000 Demo unit FDA-1986-V-0022 | Variance Approval Letter from FDA CDRH to California Technical Associates | Other | Approval for Variance (VRA) | 1994-12-30T05:00:00Z | 1994 | 12 | 2023-01-18T18:31:29Z | 0 | 0 | 090000648050dd41 | |||
| FDA-1994-P-0049-0003 | FDA | Regulate Cigarettes Containing Nicotine as Drugs or Devices-CLOSED FDA-1994-P-0049 | HFA-305 to Action on Smoking and Health (ASH) | Other | ACK-Acknowledgement Letter | 1994-12-23T05:00:00Z | 1994 | 12 | 2008-05-16T23:21:33Z | 0 | 0 | 09000064804ffa14 | |||
| FDA-1981-N-0012-0010 | FDA | OTC Weight Control Drug Products for Human Use FDA-1981-N-0012 | HFA-305 to Caprice-Greystoke, Ltd | Other | ACK-Acknowledgement Letter | 1994-12-14T05:00:00Z | 1994 | 12 | 2008-05-30T22:53:23Z | 0 | 0 | 09000064805ae8d5 | |||
| FDA-1982-P-0018-0388 | FDA | Reclassify Electroconvulsive Therapy (ECT) Section 513(E)-CLOSED FDA-1982-P-0018 | Acknowledgment Letter from FDA Dockets Management Branch to Edward R. Hutchinson | Other | Acknowledgement Letter/Receipt | 1994-12-01T05:00:00Z | 1994 | 12 | 2025-01-07T12:57:06Z | 0 | 0 | 090000648050e72b | |||
| FDA-1994-P-0045-0001 | FDA | Finished Medical Gases - Exemption from Certain Regulations-CLOSED FDA-1994-P-0045 | Acknowledgment Letter from FDA DMB to Medical Gases Committee | Other | Acknowledgement Letter/Receipt | 1994-11-28T05:00:00Z | 1994 | 11 | 2024-07-01T14:53:49Z | 0 | 0 | 09000064804ff6c5 | |||
| FDA-1994-P-0042-0001 | FDA | Revoke Guide on Buspirone Bioequivalence Testing-CLOSED FDA-1994-P-0042 | Acknowledgment Letter from FDA DMB to Fox, Bennett & Turner | Other | Acknowledgement Letter/Receipt | 1994-11-22T05:00:00Z | 1994 | 11 | 2024-06-18T15:39:19Z | 0 | 0 | 09000064804ff3dd | |||
| FDA-1981-N-0012-0011 | FDA | OTC Weight Control Drug Products for Human Use FDA-1981-N-0012 | HFA-305 to Caprice-Greystoke, Ltd | Other | ACK-Acknowledgement Letter | 1994-10-24T04:00:00Z | 1994 | 10 | 2008-05-30T22:53:23Z | 0 | 0 | 09000064805ae8d6 | |||
| FDA-1994-P-0013-0009 | FDA | Reference Amount of Wild Rice-CLOSED FDA-1994-P-0013 | Acknowledgment Letter from FDA DMB to Minnesota Cultivated Wild Rice Council | Other | Acknowledgement Letter/Receipt | 1994-10-18T04:00:00Z | 1994 | 10 | 2024-06-27T03:41:49Z | 0 | 0 | 09000064804fc7e5 | |||
| FDA-1978-N-0018-0135 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from FDA CDER to Arlington Dermatology Clinic South | Other | Letter(s) | 1994-10-17T04:00:00Z | 1994 | 10 | 2019-07-22T16:53:28Z | 0 | 0 | 090000648055a1d7 | |||
| FDA-1975-N-0012-0049 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Request for Extension from Amway Corporation | Other | Request for Extension | 1994-10-13T04:00:00Z | 1994 | 10 | 2017-11-20T17:41:08Z | 0 | 0 | 09000064805c1947 | |||
| FDA-1994-M-0011-0003 | FDA | PMA Sonic Accelerated Fracture Healing System FDA-1994-M-0011 | Approval Letter from FDA CDRH to Exogen, Inc. | Other | Approval | 1994-10-05T04:00:00Z | 1994 | 10 | 2024-06-07T15:10:49Z | 0 | 0 | 09000064804fc71e | |||
| FDA-1994-P-0034-0001 | FDA | Certify Mercury/Silver (amalgam)-Classify & Issue Warning FDA-1994-P-0034 | HFA-305 to Reeves & Graddy | Other | ACK-Acknowledgement Letter | 1994-09-27T04:00:00Z | 1994 | 9 | 2008-05-16T23:19:11Z | 0 | 0 | 09000064804fd60a | |||
| FDA-1978-N-0018-0133 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from FDA CDER to Person & Covey, Inc. | Other | Letter(s) | 1994-09-15T04:00:00Z | 1994 | 9 | 2019-07-22T15:37:29Z | 0 | 0 | 090000648055a1c0 | |||
| FDA-1985-V-0043-0001 | FDA | XISCAN MODEL 1000 DIAGNOSTIC X-RAY SYSTEM/CONFIDENTIAL FDA-1985-V-0043 | FDA/CDRH | Other | LET-Letter | 1994-09-12T04:00:00Z | 1994 | 9 | 2008-05-30T22:53:19Z | 0 | 0 | 09000064805b5d16 | |||
| FDA-1978-N-0018-0132 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Memorandum of Telephone Conversation between Arent, Fox, Kintner, Plotkin & Kahn and FDA/CDER, August 22, 1994 | Other | Memorandum | 1994-09-06T04:00:00Z | 1994 | 9 | 2019-08-02T14:52:14Z | 0 | 0 | 090000648055a19c | |||
| FDA-1994-P-0005-0001 | FDA | Issue regulations provide consistency use of term "sugar" FDA-1994-P-0005 | Acknowledgment Letter from FDA DMB to The Sugar Association | Other | Acknowledgement Letter/Receipt | 1994-08-03T04:00:00Z | 1994 | 8 | 2024-07-01T13:54:19Z | 0 | 0 | 09000064804fc55a | |||
| FDA-1994-P-0012-0009 | FDA | Amend monograph to include Valerian as OTC sleep-aid product-CLOSED FDA-1994-P-0012 | HFA-305 to Bass & Ullman, P. C. | Other | ACK-Acknowledgement Letter | 1994-07-28T04:00:00Z | 1994 | 7 | 2008-05-16T23:18:51Z | 0 | 0 | 09000064804fc786 | |||
| FDA-1994-P-0012-0010 | FDA | Amend monograph to include Valerian as OTC sleep-aid product-CLOSED FDA-1994-P-0012 | HFA-305 to Bass & Ullman, P. C. | Other | ACK-Acknowledgement Letter | 1994-07-28T04:00:00Z | 1994 | 7 | 2008-05-16T23:18:51Z | 0 | 0 | 09000064804fc787 | |||
| FDA-1978-N-0018-0129 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Correction to Memorandum of Meeting between FDA/CDER, et al., and Givauden-Roure Corporation, et al., May 11, 1994 from FDA/CDER | Other | Correction(s) | 1994-07-28T04:00:00Z | 1994 | 7 | 2019-07-23T15:57:14Z | 0 | 0 | 090000648055a12c | |||
| FDA-1978-N-0018-0459 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Acknowledgment Letter from FDA/DDM to Arent Fox Kintner Plotkin & Kahn on behalf of Estee Lauder, Inc. | Other | Acknowledgement Letter/Receipt | 1994-07-28T04:00:00Z | 1994 | 7 | 2019-07-23T15:01:45Z | 0 | 0 | 090000648055a8b8 | |||
| FDA-1978-N-0018-0128 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from FDA/CDER to Ivy Laboratories | Other | Letter(s) | 1994-07-27T04:00:00Z | 1994 | 7 | 2019-07-22T18:55:33Z | 0 | 0 | 090000648055a126 | |||
| FDA-1978-N-0018-0127 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from FDA/CDER to Temple University Medical Practices | Other | Letter(s) | 1994-07-19T04:00:00Z | 1994 | 7 | 2019-07-22T18:26:46Z | 0 | 0 | 090000648055a11b | |||
| FDA-1994-P-0028-0001 | FDA | Acknowledge Geneva's Right to 180 days of Market Exclusivity Terfenadine-CLOSED FDA-1994-P-0028 | Acknowledgment Letter from FDA DDM to Mckenna & Cuneo | Other | Acknowledgement Letter/Receipt | 1994-07-12T04:00:00Z | 1994 | 7 | 2017-10-07T21:38:33Z | 0 | 0 | 09000064804fd339 | |||
| FDA-1975-N-0016-0021 | FDA | OTC Topical Antimicrobial Drug Products - OPEN FDA-1975-N-0016 | Letter from FDA CDER to Ciba-Geigy Corporation | Other | Letter(s) | 1994-07-08T04:00:00Z | 1994 | 7 | 2017-09-25T19:36:18Z | 0 | 0 | 09000064805c2277 | |||
| FDA-1978-N-0018-0125 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Memorandum of Meeting between FDA/CDER, et al., and Givauden-Roure Corporation, et al., May 11, 1994 | Other | Memorandum | 1994-07-07T04:00:00Z | 1994 | 7 | 2019-07-22T17:58:20Z | 0 | 0 | 090000648055a116 | |||
| FDA-1994-P-0040-0001 | FDA | Establish Federal Standards of Identity for Tortillas, etc. FDA-1994-P-0040 | Acknowledgment Letter from FDA DMB to Tortilla Industry Association | Other | ACK-Acknowledgement Letter | 1994-06-30T04:00:00Z | 1994 | 6 | 2024-07-30T01:01:05Z | 0 | 0 | 09000064804fd9ce | |||
| FDA-1978-N-0018-0124 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from FDA CDER to King & Spaulding | Other | Letter(s) | 1994-06-30T04:00:00Z | 1994 | 6 | 2019-07-29T18:43:55Z | 0 | 0 | 090000648055a10e | |||
| FDA-1978-N-0018-0123 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Memorandum of Meeting between FDA/CDER, Dr. Madhu Pathak, et al., and Givaudan-Roure Corporation, et al., May 12, 1994 | Other | Memorandum | 1994-06-30T04:00:00Z | 1994 | 6 | 2019-09-04T17:19:22Z | 0 | 0 | 090000648055a10b | |||
| FDA-1994-P-0012-0008 | FDA | Amend monograph to include Valerian as OTC sleep-aid product-CLOSED FDA-1994-P-0012 | HFA-305 to Akin, Gump, Strauss, Hauer & Feld, L. L. P. | Other | ACK-Acknowledgement Letter | 1994-06-09T04:00:00Z | 1994 | 6 | 2008-05-16T23:18:51Z | 0 | 0 | 09000064804fc785 | |||
| FDA-1980-N-0057-0012 | FDA | Ophthalmic Drug Products FDA-1980-N-0057 | Petition Denial Letter from FDA (HFC-1) to Alcon Laboratories, Inc. | Other | Denial | 1994-05-26T04:00:00Z | 1994 | 5 | 2022-03-23T18:44:49Z | 0 | 0 | 09000064805ba5c0 | |||
| FDA-1994-P-0002-0002 | FDA | Modify Ingred Label for In-Store Prepared Take-Out Food FDA-1994-P-0002 | Acknowledgment Letter from FDA DMB to Food Marketing Institute | Other | Acknowledgement Letter/Receipt | 1994-05-20T04:00:00Z | 1994 | 5 | 2024-06-24T17:30:16Z | 0 | 0 | 09000064804fc4b4 | |||
| FDA-1993-P-0034-0001 | FDA | Postpone Regulations & Rules re: Calgene's FAP Aminoglycoside 3'-Phosphotransferase II (APH(3')II) in Tomatoes, Cotton and Oilseed Rape-CLOSED FDA-1993-P-0034 | Petition Denial Response Letter from FDA ORA to The Foundation on Economic Trends | Other | Denial of Petition | 1994-05-19T04:00:00Z | 1994 | 5 | 2017-06-19T15:08:07Z | 0 | 0 | 09000064804fb940 | |||
| FDA-1978-N-0018-0120 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from FDA/CDER to King & Spalding | Other | Letter(s) | 1994-05-12T04:00:00Z | 1994 | 5 | 2019-07-22T18:47:28Z | 0 | 0 | 090000648055a020 | |||
| FDA-1982-P-0018-0387 | FDA | Reclassify Electroconvulsive Therapy (ECT) Section 513(E)-CLOSED FDA-1982-P-0018 | Acknowledgement Letter from FDA Dockets Management Branch to Edward R. Hutchinson | Other | Acknowledgement Letter/Receipt | 1994-05-03T04:00:00Z | 1994 | 5 | 2025-01-06T15:53:08Z | 0 | 0 | 090000648050e72a | |||
| FDA-1981-N-0043-0008 | FDA | Pediculicide Drug Products for OTC Human Use FDA-1981-N-0043 | Acknowledgment Letter from FDA DMS to Nonprescription Drug Manufacturers Association | Other | Acknowledgement Letter/Receipt | 1994-04-25T04:00:00Z | 1994 | 4 | 2021-03-15T13:37:42Z | 0 | 0 | 09000064805af2fa | |||
| FDA-1994-P-0015-0002 | FDA | Refrain from Approving Any ANDA's for Terfenadine-CLOSED FDA-1994-P-0015 | Acknowledgment Letter from FDA DMB to Kleinfeld Kaplan & Becker | Other | Acknowledgement Letter/Receipt | 1994-04-14T04:00:00Z | 1994 | 4 | 2024-07-29T15:37:51Z | 0 | 0 | 09000064804fc971 | |||
| FDA-1994-P-0015-0001 | FDA | Refrain from Approving Any ANDA's for Terfenadine-CLOSED FDA-1994-P-0015 | Acknowledgment Letter from FDA DMB to Kleinfeld Kaplan & Becker | Other | Acknowledgement Letter/Receipt | 1994-04-14T04:00:00Z | 1994 | 4 | 2024-07-29T15:24:07Z | 0 | 0 | 09000064804fc904 | |||
| FDA-1994-P-0048-0001 | FDA | Withdraw Interim Guideline on Albuterol Inhalation Aerosols-CLOSED FDA-1994-P-0048 | Acknowledgment Letter from FDA DMB to Glaxo Inc. | Other | Acknowledgement Letter/Receipt | 1994-04-13T04:00:00Z | 1994 | 4 | 2024-06-18T13:27:13Z | 0 | 0 | 09000064804ff83a | |||
| FDA-1992-E-0012-0003 | FDA | Supprelin; Patent Extension Application No. 4,244,946 FDA-1992-E-0012 | Acknowledgement Letter from FDA Dockets Management Branch to Fitch, Even, Tabin & Flannery | Other | Acknowledgement Letter/Receipt | 1994-04-08T04:00:00Z | 1994 | 4 | 2023-09-25T11:57:36Z | 0 | 0 | 090000648052610d | |||
| FDA-1978-N-0018-0117 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Answer Letter from FDA/CDER to Dr. Beverly Summers | Other | Letter(s) | 1994-04-06T04:00:00Z | 1994 | 4 | 2019-07-22T12:23:19Z | 0 | 0 | 0900006480559fad | |||
| FDA-1978-N-0018-0119 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Answer Letter from FDA/CDER to Nicholas J. Lowe | Other | Letter(s) | 1994-04-06T04:00:00Z | 1994 | 4 | 2019-07-22T12:32:57Z | 0 | 0 | 0900006480559fd3 | |||
| FDA-1978-N-0018-0118 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Answer Letter from FDA/CDER to James L. Boren | Other | Letter(s) | 1994-04-06T04:00:00Z | 1994 | 4 | 2019-07-22T12:28:04Z | 0 | 0 | 0900006480559fb4 | |||
| FDA-1975-N-0016-0020 | FDA | OTC Topical Antimicrobial Drug Products - OPEN FDA-1975-N-0016 | Letter from FDA CDER to Johnson & Johnson Products, Inc. | Other | Letter(s) | 1994-03-30T05:00:00Z | 1994 | 3 | 2017-09-25T19:34:21Z | 0 | 0 | 09000064805c2275 | |||
| FDA-1994-N-0030-0002 | FDA | Proposal to Debar; John D. Copanos; Opportunity for Hearing FDA-1994-N-0030 | Letter from FDA DMB to John Copanos | Other | Letter(s) | 1994-03-22T05:00:00Z | 1994 | 3 | 2024-12-05T19:52:47Z | 0 | 0 | 09000064804fd3e9 | |||
| FDA-1992-N-0041-0001 | FDA | Debarment of Kun Chae Bae; Notice of Opportunity for Hearing FDA-1992-N-0041 | Letter from FDA to Kun Chae Bae | Other | Letter(s) | 1994-03-15T05:00:00Z | 1994 | 3 | 2023-08-03T14:58:26Z | 0 | 0 | 090000648052896d | |||
| FDA-1994-P-0049-0002 | FDA | Regulate Cigarettes Containing Nicotine as Drugs or Devices-CLOSED FDA-1994-P-0049 | HFA-305 to Action on Smoking and Health | Other | ACK-Acknowledgement Letter | 1994-03-09T05:00:00Z | 1994 | 3 | 2008-05-16T23:21:33Z | 0 | 0 | 09000064804ffa13 | |||
| FDA-1994-P-0049-0001 | FDA | Regulate Cigarettes Containing Nicotine as Drugs or Devices-CLOSED FDA-1994-P-0049 | HFA-305 to Action on Smoking and Health | Other | ACK-Acknowledgement Letter | 1994-03-09T05:00:00Z | 1994 | 3 | 2008-05-16T23:21:29Z | 0 | 0 | 09000064804ff866 | |||
| FDA-1993-N-0013-0006 | FDA | Improvements in the Drug Master File System FDA-1993-N-0013 | Summary of January 31, 1994 Drug Master File Workshop | Other | SUM-Summary | 1994-03-08T05:00:00Z | 1994 | 3 | 2008-05-16T23:23:57Z | 0 | 0 | 09000064804fa48f | |||
| FDA-1994-P-0001-0001 | FDA | Classify of All Cigarette Products as Drugs-CLOSED FDA-1994-P-0001 | HFA-305 to American Heart Association | Other | ACK-Acknowledgement Letter | 1994-03-08T05:00:00Z | 1994 | 3 | 2008-05-16T23:17:40Z | 0 | 0 | 09000064804f9b60 | |||
| FDA-1994-M-0009-0002 | FDA | Premarket Approval of OrthoLogic 1000 FDA-1994-M-0009 | Letter of Approval Of Application from FDA CDRH to Orthologic Corporation | Other | Approval | 1994-03-04T05:00:00Z | 1994 | 3 | 2024-05-28T13:27:00Z | 0 | 0 | 09000064804fc62f | |||
| FDA-1993-N-0013-0002 | FDA | Improvements in the Drug Master File System FDA-1993-N-0013 | Transcript of the January 31, 1994 meeting | Other | TR-Transcript | 1994-03-01T05:00:00Z | 1994 | 3 | 2008-05-16T23:23:57Z | 0 | 0 | 09000064804fa460 | |||
| FDA-1993-N-0013-0003 | FDA | Improvements in the Drug Master File System FDA-1993-N-0013 | Transcript of the January 31, 1994 meeting | Other | TR-Transcript | 1994-03-01T05:00:00Z | 1994 | 3 | 2008-05-16T23:23:57Z | 0 | 0 | 09000064804fa471 | |||
| FDA-1981-N-0043-0007 | FDA | Pediculicide Drug Products for OTC Human Use FDA-1981-N-0043 | Acknowledgment Letter from FDA DMS to Nonprescription Drug Manufacturers Association | Other | Acknowledgement Letter/Receipt | 1994-03-01T05:00:00Z | 1994 | 3 | 2021-03-15T13:38:22Z | 0 | 0 | 09000064805af2f9 | |||
| FDA-1993-N-0013-0004 | FDA | Improvements in the Drug Master File System FDA-1993-N-0013 | Transcript of the January 31, 1994 meeting | Other | TR-Transcript | 1994-03-01T05:00:00Z | 1994 | 3 | 2008-05-16T23:23:57Z | 0 | 0 | 09000064804fa47b | |||
| FDA-1993-N-0013-0005 | FDA | Improvements in the Drug Master File System FDA-1993-N-0013 | Transcript of the January 31, 1994 meeting | Other | TR-Transcript | 1994-03-01T05:00:00Z | 1994 | 3 | 2008-05-16T23:23:57Z | 0 | 0 | 09000064804fa482 | |||
| FDA-1978-N-0018-0116 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from FDA/CDER to Morgan, Lewis & Bockius | Other | Letter(s) | 1994-02-28T05:00:00Z | 1994 | 2 | 2019-07-26T11:46:52Z | 0 | 0 | 0900006480559ec3 | |||
| FDA-1980-P-0012-0011 | FDA | Showlasers model LP1-CLOSED FDA-1980-P-0012 | Approval for Variance from FDA/CDRH to Showlasers, Inc. | Other | Approval for Variance (VRA) | 1994-02-24T05:00:00Z | 1994 | 2 | 2021-02-24T16:45:05Z | 0 | 0 | 09000064805b926a | |||
| FDA-1978-N-0018-0465 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Answer Letter from FDA/Associate Commissioner for Legislative Affairs to Comment from the Honorable Congressman Bob Clement | Other | Answer | 1994-02-24T05:00:00Z | 1994 | 2 | 2019-07-19T11:59:16Z | 0 | 0 | 090000648055a8c9 | |||
| FDA-1978-N-0018-0466 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Answer Letter from FDA/Associate Commissioner for Legislative Affairs to Comment from the Honorable Senator Harlan Mathews | Other | Answer | 1994-02-24T05:00:00Z | 1994 | 2 | 2019-07-19T12:09:07Z | 0 | 0 | 090000648055a8cd | |||
| FDA-1991-V-0023-0002 | FDA | Las Vegas laser rental light shows. FDA-1991-V-0023 | Variance Approval Letter from FDA CDRH to Las Vegas Laser Rental | Other | Approval for Variance (VRA) | 1994-02-24T05:00:00Z | 1994 | 2 | 2023-10-13T11:54:31Z | 0 | 0 | 090000648052867d | |||
| FDA-1978-N-0018-0111 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from FDA/CDER to The Proctor & Gamble Company | Other | Letter(s) | 1994-02-17T05:00:00Z | 1994 | 2 | 2019-07-26T11:53:00Z | 0 | 0 | 0900006480559e6e | |||
| FDA-1994-P-0041-0229 | FDA | Require Labeling of Trans Fatty Acid & Prohibit Deceptive Claims-CLOSED FDA-1994-P-0041 | HFA-305 to Center for Science in the Public Interest | Other | ACK-Acknowledgement Letter | 1994-02-15T05:00:00Z | 1994 | 2 | 2008-05-16T23:19:19Z | 0 | 0 | 09000064804ff053 | |||
| FDA-1980-N-0074-0031 | FDA | Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 | Letter from FDA HFD-810 to Church and Dwight Company, Inc. | Other | Letter(s) | 1994-02-10T05:00:00Z | 1994 | 2 | 2022-04-21T20:25:03Z | 0 | 0 | 09000064805bb361 | |||
| FDA-1993-N-0050-0003 | FDA | Health Claims for Antioxidant Vitamins & Cancer FDA-1993-N-0050 | HFA-305 to Dilling and Dilling | Other | ACK-Acknowledgement Letter | 1994-02-07T05:00:00Z | 1994 | 2 | 2008-05-16T23:24:13Z | 0 | 0 | 09000064804fc566 | |||
| FDA-1978-N-0018-0108 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from FDA/CDER to The Proctor & Gamble Company | Other | Letter(s) | 1994-01-26T05:00:00Z | 1994 | 1 | 2019-08-05T12:27:33Z | 0 | 0 | 0900006480559e05 | |||
| FDA-1978-N-0018-0109 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from FDA/CDER to Nonprescription Drug Manufacturers Association | Other | Letter(s) | 1994-01-26T05:00:00Z | 1994 | 1 | 2019-08-05T12:25:05Z | 0 | 0 | 0900006480559e09 | |||
| FDA-1978-N-0018-0110 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from FDA/CDER to The Cosmetic, Toiletry & Fragrance Association | Other | Letter(s) | 1994-01-26T05:00:00Z | 1994 | 1 | 2019-08-05T12:21:30Z | 0 | 0 | 0900006480559e0c | |||
| FDA-1978-N-0018-0107 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from SunSmart Inc. to FDA/CDER | Other | Letter(s) | 1994-01-10T05:00:00Z | 1994 | 1 | 2019-08-05T12:48:55Z | 0 | 0 | 0900006480559dfc | |||
| FDA-1978-N-0018-0106 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Memorandum of Meeting between FDA/CDER and Cosmetic, Toiletry, and Fragrance Association October 21 1993 | Other | Memorandum | 1994-01-10T05:00:00Z | 1994 | 1 | 2019-08-05T12:57:30Z | 0 | 0 | 0900006480559df7 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);